Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease

A Caporali, M Anwar, Y Devaux, R Katare… - Nature Reviews …, 2024 - nature.com
The adult heart is a complex, multicellular organ that is subjected to a series of regulatory
stimuli and circuits and has poor reparative potential. Despite progress in our understanding …

The microRNA expression profiling in heart failure: A systematic review and meta-analysis

NN Shen, JL Wang, Y Fu - Frontiers in Cardiovascular Medicine, 2022 - frontiersin.org
Background Heart failure (HF) is a main consequence of cardiovascular diseases
worldwide. Abnormal expression levels of microRNAs (miRNAs) in HF are observed in …

Inhibition of the long non‐coding RNA ZFAS1 attenuates ferroptosis by sponging miR‐150‐5p and activates CCND2 against diabetic cardiomyopathy

T Ni, X Huang, S Pan, Z Lu - Journal of Cellular and Molecular …, 2021 - Wiley Online Library
Diabetic cardiomyopathy (DbCM) is responsible for increased morbidity and mortality in
patients with diabetes and heart failure. However, the pathogenesis of DbCM has not yet …

miR-4732-3p in extracellular vesicles from mesenchymal stromal cells is cardioprotective during myocardial ischemia

R Sánchez-Sánchez, M Gómez-Ferrer… - Frontiers in cell and …, 2021 - frontiersin.org
Extracellular vesicles (EVs) derived from mesenchymal stromal cells (MSCs) are an
emerging alternative to cell-based therapies to treat many diseases. However, the …

A meta-analysis of microRNA expression profiling studies in heart failure

A Gholaminejad, N Zare, N Dana, D Shafie, A Mani… - Heart Failure …, 2021 - Springer
Heart failure (HF) is a major consequence of many cardiovascular diseases with high rate of
morbidity and mortality. Early diagnosis and prevention are hampered by the lack of …

SP1‐induced SNHG14 aggravates hypertrophic response in in vitro model of cardiac hypertrophy via up‐regulation of PCDH17

Y Long, L Wang, Z Li - Journal of Cellular and Molecular …, 2020 - Wiley Online Library
Cardiac hypertrophy (CH) is a common cardiac disease and is closely associated with heart
failure. Protocadherin 17 (PCDH17) was reported to aggravate myocardial infarction …

Role of Different Types of miRNAs in Some Cardiovascular Diseases and Therapy‐Based miRNA Strategies: A Mini Review

SS Fayez, SM Mishlish, HM Saied… - BioMed Research …, 2022 - Wiley Online Library
The role of microRNAs (miRNAs) in the pathogenesis of cardiovascular disease has been
extensively studied. miRNAs have been highlighted as an important physiological regulator …

Circulating circular RNAs: novel biomarkers for heart failure

C Sun, M Ni, B Song, L Cao - Frontiers in Pharmacology, 2020 - frontiersin.org
Heart failure (HF) is a serious, chronic disease, causing significant ill health and high
mortality worldwide. The current clinical strategies emphasize reducing the transition from a …

Characterization of micro-RNA in women with different ovarian reserve

M Abu-Halima, LS Becker, BM Ayesh, SL Baus… - Scientific Reports, 2021 - nature.com
Women undergoing infertility treatment are routinely subjected to one or more tests of
ovarian reserve. Therefore, an adequate assessment of the ovarian reserve is necessary for …

[HTML][HTML] Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy

Z Song, J Wang, L Zhang - International Journal of Medical …, 2024 - ncbi.nlm.nih.gov
Diabetic cardiomyopathy (DC) is a pathophysiologic condition caused by diabetes mellitus
(DM) in the absence of coronary artery disease, valvular heart disease, and hypertension …